Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.
Postgrad Med J. 2022 Sep 1;98(1163):666-669. doi: 10.1136/postgradmedj-2021-140319.
Postgrad Med J. 2022.
PMID: 37062975
Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater.
Lee WL, Armas F, Guarneri F, Gu X, Formenti N, Wu F, Chandra F, Parisio G, Chen H, Xiao A, Romeo C, Scali F, Tonni M, Leifels M, Chua FJD, Kwok GW, Tay JY, Pasquali P, Thompson J, Alborali GL, Alm EJ.
Lee WL, et al. Among authors: kwok gw.
Water Res. 2022 Aug 1;221:118809. doi: 10.1016/j.watres.2022.118809. Epub 2022 Jul 2.
Water Res. 2022.
PMID: 35841797
Free PMC article.
Item in Clipboard
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy.
Chiu JW, Leung R, Tang V, Cheuk WY, Lo J, Kwok GW, Wong H, Suen D, Cheung P, Wong TT, Yau T, Kwong A.
Chiu JW, et al. Among authors: kwok gw.
Postgrad Med J. 2019 Mar;95(1121):155-161. doi: 10.1136/postgradmedj-2018-135739. Epub 2019 Apr 19.
Postgrad Med J. 2019.
PMID: 31004045
Item in Clipboard
Cite
Cite